Elevated uPAR levels have been correlated with poor prognosis in several cancers, including breast, prostate, melanoma and colorectal cancers, where it enhances tumor invasiveness and metastatic potential [14,29,30,31,32,33,34,35,36,37,38,39]. This evidence concerns the gene PLAUR and neoplasm.